GlucoTrack, Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported net loss was USD 1.29 million compared to USD 1.09 million a year ago. Basic loss per share from continuing operations was USD 0.08 compared to USD 0.07 a year ago.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5599 USD | +4.65% | +16.89% | +114.11% |
Apr. 22 | GlucoTrack, Inc. announced that it has received $0.5 million in funding | CI |
Apr. 16 | Glucotrack Expanding Glucose Monitoring Technology to Epidural Space | MT |
1st Jan change | Capi. | |
---|---|---|
+114.11% | 14.31M | |
+0.26% | 42.19B | |
+44.30% | 40.15B | |
-6.20% | 28.31B | |
+5.91% | 24.63B | |
-24.16% | 18.2B | |
+26.81% | 12.01B | |
-3.46% | 11.76B | |
+9.93% | 10.4B | |
-1.62% | 9.94B |
- Stock Market
- Equities
- GCTK Stock
- News GlucoTrack, Inc.
- GlucoTrack, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023